Agios to Webcast Conference Call of First Quarter 2019 Financial Results on May 2, 2019
April 25 2019 - 4:00PM
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field
of cellular metabolism to treat cancer and rare genetic diseases,
today announced that the company will host a conference call and
live webcast on Thursday, May 2, 2019 at 8:00 a.m. ET to report its
first quarter 2019 financial results and other business highlights.
A live webcast can be accessed under "Events &
Presentations" in the Investors section of the company's website at
www.agios.com. The conference call can be accessed by dialing
1-877-377-7098 (domestic) or 1-631-291-4547 (international) and
referring to conference ID 9573049. The webcast will be archived
and made available for replay on the company's website beginning
approximately two hours after the event.
About AgiosAgios is focused on discovering and
developing novel investigational medicines to treat cancer and rare
genetic diseases through scientific leadership in the field of
cellular metabolism and adjacent areas of biology. In addition to
an active research and discovery pipeline across both therapeutic
areas, Agios has two approved oncology precision medicines and
multiple first-in-class investigational therapies in clinical
and/or preclinical development. All Agios programs focus on
genetically identified patient populations, leveraging our
knowledge of metabolism, biology and genomics. For more
information, please visit the company's website at
www.agios.com.
Contacts
Investor & Media Contact:Holly Manning,
617-844-6630Associate Director, Investor
RelationsHolly.Manning@agios.com
Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
From Apr 2023 to Apr 2024